公开(公告)号：US20240021284A1

公开(公告)日：2024-01-18

申请号：US18220565

申请日：2023-07-11

Applicant: Dexcom, Inc.

Inventor： Nathanael R. Paul ,  Apurv ULLAS Kamath

IPC: G16H20/17 ,  A61M5/142 ,  A61M5/172

CPC classification number: G16H20/17 ,  A61M5/142 ,  A61M5/1723 ,  A61M2005/14208 ,  A61M2230/201

Abstract: Location-aided glycemic control is described. A glycemic control system obtains sensor data is from one or more sensors, and detects a location of a user based on the sensor data. The glycemic control system predicts an activity that the user will perform at the location based on the location of the user, and generates a recommendation to control a glycemic response of the user to the predicted activity. In one or more implementations the glycemic control system causes display of the recommendation to control the glycemic response of the user. In one or more implementations the recommendation corresponds to administering an amount of a medicament to the user to control the glycemic response to the predicted activity, and the glycemic control system communicates instructions to a medicament delivery system which causes the medicament delivery system to administer the amount of the medicament to the user.

公开(公告)号：US20240066223A1

公开(公告)日：2024-02-29

申请号：US18361827

申请日：2023-07-29

Applicant: Dexcom, Inc.

Inventor： Nathanael R. Paul

IPC: A61M5/172 ,  A61M5/142

CPC classification number: A61M5/1723 ,  A61M5/14248 ,  A61M2205/3553 ,  A61M2205/50 ,  A61M2230/201 ,  A61M2230/63

Abstract: Automatic suspension and resumption of medicament delivery is described. In one or more implementations, a request to suspend delivery of a medicament to a user is received. A medicament delivery system is controlled to suspend delivery of the medicament to the user, and to automatically resume medicament delivery to the user after a suspension time period. In one or more implementations, a medicament delivery system is controlled to suspend delivery of a medicament to a user during performance of an activity, and to automatically resume delivery of the medicament to the user after performance of the activity is completed. In one or more implementations, a medicament delivery system is controlled to suspend medicament delivery to a user at a first time based on a location of the user, and to resume medicament delivery to the user at a second time based on a subsequent location of the user.